Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Cardiovascular disease in chronic myelomonocytic leukemia: do monocytosis and chronic inflammation predispose to accelerated atherosclerosis?

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Elevated levels of oxidized nucleosides in individuals with the JAK2V617F mutation from a general population study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The red blood cell count and the erythrocyte sedimentation rate in the diagnosis of polycythaemia vera

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Patients with chronic myelomonocytic leukemia (CMML) have monocytosis and likely a state of chronic inflammation. Both have been associated with an increased risk of atherosclerosis. The aim of the study was to test the hypothesis that CMML patients are at increased risk of developing cardiovascular disease (CVD) due to persistent monocytosis and sustained chronic inflammation. In a retrospective cohort study, we assessed hazards for cardiovascular events after diagnosis in 112 CMML patients and 231 chronic lymphocytic leukemia (CLL) patients. Analyses were carried out on restricted cohorts (CMML = 84, CLL = 186), excluding patients with a prior history of CVD, as well as on unrestricted cohorts. In the restricted cohorts, a significant effect of cardiovascular event occurrence did not remain after adjustment (HR 2.49, 95% CI 0.94-6.60). In unrestricted cohorts, we found a more than twofold increased rate of cardiovascular events in CMML (HR 2.34, 95% CI 1.05-5.20). Our results indicate an increased risk of CVD after the diagnosis in CMML patients.

OriginalsprogEngelsk
TidsskriftAnnals of Hematology
Vol/bind98
Udgave nummer1
Sider (fra-til)101-109
Antal sider9
ISSN0939-5555
DOI
StatusUdgivet - 2019

Bibliografisk note

Institute for Inflammation Research

ID: 55229635